Publication Name	World Journal of Gastrointestinal Surgery
Manuscript ID	22688
Country	Italy

Received	2015-09-15 08:21
Peer-Review Started	2015-09-17 12:02
To Make the First Decision	2015-10-27 11:16
Return for Revision	2015-10-30 16:10
Revised	2015-11-28 03:30
Second Decision	2015-12-24 17:50
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2016-01-11 15:39
Articles in Press	2016-01-11 15:39
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-03-14 17:54
Publish the Manuscript Online	2016-03-20 21:10

ISSN	1948-9366 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Relevance of fecal calprotectin and lactoferrin in the post-operative management of inflammatory bowel diseases
Manuscript Source	Invited Manuscript
All Author List	Roberta Caccaro, Imerio Angriman and Renata D’Incà
Funding Agency and Grant Number
Corresponding Author	Roberta Caccaro, MD, PhD, Department of Surgery, Oncology and Gastroenterology, Gastroenterology Section, University Hospital of Padua, via Giustiniani 2, 35128 Padua, Italy. roberta.caccaro@gmail.com
Key Words	Calprotectin; Lactoferrin; Fecal markers; Inflammatory bowel disease; Post-operative; Surgery; Crohn’s disease; Ulcerative colitis
Core Tip	Inflammatory bowel diseases (IBDs) are chronic conditions, requiring life-long therapy and monitoring. Surgery is not curative and the disease might recur after operation as post-operative recurrence in Crohn’s disease patients and pouchitis in ulcerative colitis patients. In both cases, endoscopy with histology is the gold standard procedure to assess disease activity. Non-invasive markers of intestinal inflammation, such as fecal calprotectin and lactoferrin, might be useful in the post-operative management of IBD patients, in order to identify individuals requiring endoscopy, so that they can avoid unnecessary invasive investigations. This paper reviews the current knowledge on the use of fecal markers in this specific setting.
Publish Date	2016-03-20 21:10
Citation	Caccaro R, Angriman I, D’Incà R. Relevance of fecal calprotectin and lactoferrin in the post-operative management of inflammatory bowel diseases. World J Gastrointest Surg 2016; 8(3): 193-201
URL	http://www.wjgnet.com/1948-9366/full/v8/i3/193.htm
DOI	http://dx.doi.org/10.4240/wjgs.v8.i3.193

Full Article (PDF)	WJGS-8-193.pdf
Full Article (Word)	WJGS-8-193.doc
Manuscript File	22688-Review.docx
Answering Reviewers	22688-Answering reviewers.pdf
Audio Core Tip	22688-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	22688-Conflict-of-interest statement.pdf
Copyright License Agreement	22688-Copyright assignment.pdf
Peer-review Report	22688-Peer-review(s).pdf
Scientific Misconduct Check	22688-Scientific misconduct check.pdf
Scientific Editor Work List	22688-Scientific editor work list.pdf